Title:
PHARMACEUTICAL COMPOSITION CONTAINING LK8 PROTEIN AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING DIABETIC RETINOPATHY OR AGE-RELATED MACULAR DEGENERATION
Document Type and Number:
WIPO Patent Application WO/2012/067427
Kind Code:
A2
Abstract:
The present invention relates to a pharmaceutical composition containing, as an active ingredient, LK8 protein having an amino acid sequence depicted in sequence identification number 1, for preventing or treating diabetic retinopathy or age-related macular degeneration. The LK8 protein has an effect of inhibiting a bond between fibronectin and vascular endothelial cells, and therefore, can be valuably used as a composition for preventing or treating diabetic retinopathy or age-related macular degeneration.
Inventors:
AHN JIN-HYUNG (KR)
LIM YANG MI (KR)
KIM JEONG HUN (KR)
YU HYUN-KYUNG (KR)
CHOI HANA (KR)
YOON YEUP (KR)
HWANG YU KYEONG (KR)
LIM YANG MI (KR)
KIM JEONG HUN (KR)
YU HYUN-KYUNG (KR)
CHOI HANA (KR)
YOON YEUP (KR)
HWANG YU KYEONG (KR)
Application Number:
PCT/KR2011/008761
Publication Date:
May 24, 2012
Filing Date:
November 16, 2011
Export Citation:
Assignee:
MOGAM BIOTECH RES INST (KR)
AHN JIN-HYUNG (KR)
LIM YANG MI (KR)
KIM JEONG HUN (KR)
YU HYUN-KYUNG (KR)
CHOI HANA (KR)
YOON YEUP (KR)
HWANG YU KYEONG (KR)
AHN JIN-HYUNG (KR)
LIM YANG MI (KR)
KIM JEONG HUN (KR)
YU HYUN-KYUNG (KR)
CHOI HANA (KR)
YOON YEUP (KR)
HWANG YU KYEONG (KR)
International Classes:
A61K38/16; A61P3/10; A61P27/00; A61P27/02
Domestic Patent References:
| WO2004073730A1 | 2004-09-02 |
Foreign References:
| US7285277B2 | 2007-10-23 | |||
| US20100196370A1 | 2010-08-05 | |||
| US6743428B1 | 2004-06-01 |
Attorney, Agent or Firm:
FIRSTLAW P.C. (275-7 Yangjae-Dong Seocho-Ku, Seoul 137-739, KR)
Download PDF:
Claims: